Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

0.0%

0 terminated/withdrawn out of 4 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 2 completed trials have results

Key Signals

Enrollment Performance

Analytics

N/A
2(100.0%)
2Total
N/A(2)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (4)

Showing 4 of 4 trials
NCT02873052Completed

MyoVista Measurements in Patients With Atherosclerosis and CAD

Role: collaborator

NCT05364541Not ApplicableUnknown

MyoVista wavECG Clinical Evaluation: >=60 y/o Enrichment Population

Role: lead

NCT04804969Unknown

MyoVista wavECG Clinical Validation Study Versus Low e' on Echocardiogram

Role: lead

NCT02560168Not ApplicableCompleted

Analysis of Surface EKG Signals to Identify Myocardial Dysfunction in Patients at Risk for Coronary Artery Disease

Role: collaborator

All 4 trials loaded